• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Investigation Report on China's Esomeprazole Market, 2009-2018 Product Image

Investigation Report on China's Esomeprazole Market, 2009-2018

  • ID: 2770932
  • March 2014
  • Region: China
  • 40 Pages
  • China Research & Intelligence

Digestive system disease is one of the most frequently occurring diseases. According to statistics from WHO, there are at least 250 million people worldwide suffering from digestive system diseases, especially canker.

Inhibition of gastric acid secretion is the key treatment method for peptic ulcer, duodenal ulcer and gastroesophageal reflux disease. The H+ / K+ ATPase in gastric parietal cells can reduce gastric acid secretion. By inhibiting the functioning of this transporter, the drug prevents formation of gastric acid.

The international drug market is always enthusiastic about anti-ulcer drug development. It is very easy for products launched in the market to become bestsellers. Esomeprazole is an outstanding example. Total sales revenue of Nexium (trade name of esomeprazole produced by Astra Zeneca) is over tens of billions dollars, making it one of the most important products from Astra Zeneca. Esomeprazole is a proton pump inhibitor that appeared on the market in 2000. It is popular in the market because of high bioavailability, effective and lasting inhibition of gastric acid and low toxic and side effect. Once Ranbaxy Laboratories Limited submitted the application READ MORE >

1 Relevant Concepts of Esomeprazole
1.1 Development Process and Indication
1.2 Sales Status on the Global Market

2 Market Overview of Esomeprazole in China, 2009-2013
2.1 Major Manufacturers
2.2 Patent Status
2.3 Market Size

3 Investigation on Sales Value of Esomeprazole in China, 2009-2013
3.1 Total Sales Value
3.2 Sales Value by Region

4 Investigation on Market Share of Major Esomeprazole Manufacturers in China, 2009-2013
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Investigation on Market Size of Esomeprazole by Dosage Form in China, 2009-2013
5.1 Market Share by Sales Value and Dosage Form
5.2 Market Share by Sales Volume and Dosage Form

6 Reference Price of Esomeprazole Produced by Different Enterprises in China Hospital Market, 2014
6.1 AstraZeneca(Wuxi)
6.2 AstraZeneca(Sweden)
6.3 Zhejiang Xianju Pharmaceutical Co., Ltd.

7 Major Manufacturing Enterprises in China Esomeprazole Market, 2009-2014
7.1 Boehringer Ingelheim
7.2 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
7.3 Zhejiang Xianju Pharmaceutical Co., Ltd.

8 Prospect of China Esomeprazole Market, 2014-2018
8.1 Incidence Trend of Digestive System Diseases in China
8.2 Status of Generic Drug
8.3 Forecast on Market Size
8.4 Forecast on Competition Pattern

Selected Charts

Chart Esomeprazole Products Approved to Market in China by 2014
Chart Sales Value of Esomeprazole in Global Market, 2009-2013
Chart Esomeprazole Products Approved in China Market
Chart Patent Status of Esomeprazole in China
Chart Sales Value of Esomeprazole in China Hospital Market, 2009-2013
Chart Sales Value of Esomeprazole by Region in China, 2009-2013
Chart Market Share of Esomeprazole Enterprises by Sales Value in China, 2009-2013
Chart Price of Esomeprazole Produced by Boehringer Ingelheim in China Hospital Market, 2014
Chart Forecast on Market Size of Hospital-use Esomeprazole in China, 2014-2018

- Boehringer Ingelheim
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Zhejiang Xianju Pharmaceutical Co., Ltd.

Note: Product cover images may vary from those shown

ALSO AVAILABLE IN THE FOLLOWING LANGUAGES

RELATED PRODUCTS

Our Clients

Our clients' logos